Physician profile
Romel Antolin
NPI 1750477147
$1,189.91
in general payments reported to CMS, 2019-2025
20 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $312 · 2020: $84.67 · 2021: $96.06 · 2022: $260 · 2023: $74.58 · 2024: $90.65 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $437.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $436.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $287.20 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Astellas Pharma US INC | $153.93 | 2021-2025 | Veozah |
| Pfizer INC. | $142.82 | 2019-2022 | |
| Biogen, INC. | $68.05 | 2025 | Zurzuvae |
| Hologic Sales and Service, LLC | $62.53 | 2019-2022 | |
| Exeltis, USA INC. | $56.36 | 2021-2024 | Slynd |
| Coopersurgical, INC. | $53.02 | 2019-2025 | Paragard T 380a |
| Myovant Sciences INC. | $48.25 | 2022 | |
| Boston Scientific Corporation | $47.04 | 2025 | Axonics |
| Duchesnay USA Incorporated | $44.98 | 2019 | |
| Millicent US INC | $36.27 | 2024 | Intrarosa |
| Exact Sciences Corporation | $32.00 | 2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Roche Diagnostics Corporation | $30.72 | 2019 | |
| Mayne Pharma Commercial LLC | $27.87 | 2023 | |
| Merck Sharp & Dohme LLC | $26.02 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $16.92 | 2021 | |
| Axonics, INC. | $15.78 | 2022 | |
| Nevro Corp. | $15.06 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.73 | 2020 | |
| Therapeuticsmd, INC. | $12.36 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Romel Antolin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.